FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Rubicon Research Private Metoprolol Tartrate Tablets Recall

Metoprolol Tartrate Tablets, USP 25 mg, 1000 - count bottle, Rx Only, Distributed by: T…

Rubicon Research Private Limited · Ambernath, N/A

Risk level
Class II
Reported by FDA
Jan 19, 2022
Recall ID
D-0362-2022
Check your lot numberHow we source this data

Summary

Rubicon Research Private recalled Metoprolol Tartrate Tablets starting Dec 31, 2021. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0362-2022 on Jan 19, 2022. Reason: Complaint received of foreign matter (metal) embedded in tablet. Status: Terminated.

Why it was recalled

Complaint received of foreign matter (metal) embedded in tablet.

Product description

Metoprolol Tartrate Tablets, USP 25 mg, 1000 - count bottle, Rx Only, Distributed by: TruPharma, LLC. Tampa, FL 33609; Manufactured by: Rubicon Research Prvate Limited Ambernath, Dist. Thane, 421506 India. NDC 52817-360-00

Lot numbers, UPCs & expiration codes

Batch # 210211H1, Exp. date FEB 2024

Where it was sold

Product was distributed to one distributor who may have distributed the product further nationwide.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0362-2022
Classification
Class II
Status
Terminated
Recall initiated
Dec 31, 2021
FDA report date
Jan 19, 2022
Quantity
3,684 1000-count bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Rubicon Research Private Limited

Original FDA data

Every field from FDA enforcement report D-0362-2022, exactly as published.

Show all FDA fields
City
Ambernath
Status
Terminated
Country
India
Event ID
89311
Address
4 & K 30 5 Plot No K 30
Code information
Batch # 210211H1, Exp. date FEB 2024
Report date
Jan 19, 2022
Product type
Drugs
Recall number
D-0362-2022
Classification
Class II
Recalling firm
Rubicon Research Private Limited
Product quantity
3,684 1000-count bottles
Termination date
Nov 4, 2022
Reason for recall
Complaint received of foreign matter (metal) embedded in tablet.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Metoprolol Tartrate Tablets, USP 25 mg, 1000 - count bottle, Rx Only, Distributed by: TruPharma, LLC. Tampa, FL 33609; Manufactured by: Rubicon Research Prvate Limited Ambernath, Dist. Thane, 421506 India. NDC 52817-360-00
Distribution pattern
Product was distributed to one distributor who may have distributed the product further nationwide.
Recall initiation date
Dec 31, 2021
Initial firm notification
Letter
Center classification date
Jan 7, 2022

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0362-2022, published Jan 19, 2022. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls